Literature DB >> 24288385

Correlation of ELISA optical density with clinical diagnosis of heparin-induced thrombocytopenia: a retrospective study of 104 patients with positive anti-PF4/heparin ELISA.

Marc-André Pearson1, Chantal Nadeau, Normand Blais.   

Abstract

BACKGROUND: Enzyme-linked immunosorbent assay (ELISA) for antiplatelet factor 4 (anti-PF4)/heparin antibodies is expressed in terms of optical density (OD). Previous studies have shown correlation between OD and heparin-induced thrombocytopenia (HIT) diagnosis. However, these were mainly laboratory based.
OBJECTIVE: Retrospective correlation of clinical HIT to ELISA OD. PATIENTS/
METHODS: We conducted a retrospective study involving 104 patients with a positive ELISA for anti-PF4/heparin antibodies between 2008 and May 2012. For each patient, a clinical diagnosis was adjudicated based on different features including "4T scores," laboratory results, and a 3-month clinical follow-up.
RESULTS: In this study, 28.8% of the patients were HIT positive, and 71.2% HIT negative. Patients with positive diagnosis had significantly higher mean OD (2.15 ± 0.76 vs 0.83 ± 0.62). Patients with OD <1.0 only had 3.4% positive diagnosis versus 45.5% for OD 1.0 to 2.0 and 78% for >2.0 units.
CONCLUSION: This study is a clinical confirmation that ELISA OD results are correlated with the probability of a clinical diagnosis of HIT.

Entities:  

Keywords:  ELISA; HIT; antiheparin antibody; diagnosis; optical density

Mesh:

Substances:

Year:  2013        PMID: 24288385     DOI: 10.1177/1076029613513319

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN: 1076-0296            Impact factor:   2.389


  7 in total

1.  Progressive thrombocytopenia after cardiac surgery in a 67-year-old man.

Authors:  Ilana Kopolovic; Theodore E Warkentin
Journal:  CMAJ       Date:  2014-04-22       Impact factor: 8.262

2.  Association between the HLA-DRB1*03:01-DQB1*02:01 haplotype and PF4/heparin antibodies.

Authors:  Ray Zhang; Brian F Duffy; Vinzenz Lange; Charles S Eby; Chang Liu
Journal:  Blood Adv       Date:  2019-10-22

3.  Serum levels of anti-PF4 IgG after AZD1222 (ChAdOx1 nCoV-19) vaccination.

Authors:  Taylor S Cohen; Elizabeth J Kelly; Sven Nylander; Himanshu Bansal; Brett M Jepson; Prakash Bhuyan; Magdalena E Sobieszczyk; Ann R Falsey
Journal:  Sci Rep       Date:  2022-05-13       Impact factor: 4.996

4.  Using information theory to optimize a diagnostic threshold to match physician-ordering practice.

Authors:  Mark A Zaydman; Jonathan R Brestoff; Ronald Jackups
Journal:  J Biomed Inform       Date:  2021-03-22       Impact factor: 6.317

5.  A retrospective evaluation of fondaparinux for confirmed or suspected heparin-induced thrombocytopenia in left-ventricular-assist device patients.

Authors:  Scott T Benken; Nicholas Tillman; Suhuir Dajani; Aesha Shah; Toby Thomas
Journal:  J Cardiothorac Surg       Date:  2014-03-21       Impact factor: 1.637

6.  Injection Site Erythema in a Patient on Therapeutic Anticoagulation with Low Molecular Weight Heparin after Mechanical Aortic Valve Replacement: A Rare Presentation of Heparin- and Protamine-Induced Thrombocytopenia.

Authors:  Caroline Holaubek; Paul Simon; Sabine Eichinger-Hasenauer; Franz Gremmel; Barbara Steinlechner
Journal:  Case Reports Immunol       Date:  2020-04-10

7.  Clinical and laboratory characteristics associated with a high optical density anti-platelet factor 4 ELISA test.

Authors:  Benjamin Y Lu; David Kudlowitz; Lawrence B Gardner
Journal:  J Blood Med       Date:  2015-11-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.